Research Progress in Distinguishing Methods of Simultaneous Multiple Primary Lung Cancer and Intrapulmonary Metastasis.
10.3779/j.issn.1009-3419.2021.101.12
- Author:
Jifan WANG
1
,
2
;
Te ZHANG
1
,
2
;
Hanlin DING
1
,
2
;
Gaochao DONG
1
,
2
;
Lin XU
1
,
2
;
Feng JIANG
1
,
2
Author Information
1. Department of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research
2. Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
- Publication Type:Journal Article
- Keywords:
Accurate diagnosis;
Intrapulmonary metastasis;
Lung neoplasms;
Multiple primary lung cancer
- From:
Chinese Journal of Lung Cancer
2021;24(5):365-371
- CountryChina
- Language:Chinese
-
Abstract:
Multiple primary lung cancer (MPLC) refers to lung cancer in which two or more primary lesions occurred simultaneously or successively in different parts of the same patient's lungs. The diagnosis interval is 6 months. MPLC is divided into synchronous MPLC (sMPLC) and metachronous MPLC (mMPLC). sMPLC and intrapulmonary metastasis (IM) are different in treatment strategies and prognosis. However, there are many controversies about the distinction between the two in clinical practice. This article summarizes the current main methods of diagnosing MPLC, and focuses on the latest research progress in distinguishing MPLC from IM. It aims to provide a theoretical basis for accurate diagnosis and treatment of patients with multifocal lung cancer.
.